# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-25-043232
Filing Date
2025-09-30
Accepted
2025-09-30 16:19:43
Documents
116
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | nbx-20250630.htm iXBRL | 6-K | 1743592
| Complete submission text file | 0001628280-25-043232.txt |  | 11416621

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | nbx-20250630.xsd | EX-101.SCH | 116897
3 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | nbx-20250630_cal.xml | EX-101.CAL | 102067
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | nbx-20250630_def.xml | EX-101.DEF | 414886
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | nbx-20250630_lab.xml | EX-101.LAB | 794097
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | nbx-20250630_pre.xml | EX-101.PRE | 640047
118 | EXTRACTED XBRL INSTANCE DOCUMENT | nbx-20250630_htm.xml | XML | 2285064

Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39777 | Film No.: 251360722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)